| Product NDC: | 0703-3427 |
| Proprietary Name: | Ifosfamide |
| Non Proprietary Name: | Ifosfamide |
| Active Ingredient(s): | 1 g/20mL & nbsp; Ifosfamide |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0703-3427 |
| Labeler Name: | Teva Parenteral Medicines, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076657 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070726 |
| Package NDC: | 0703-3427-11 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (0703-3427-11) > 20 mL in 1 VIAL, SINGLE-DOSE |
| NDC Code | 0703-3427-11 |
| Proprietary Name | Ifosfamide |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (0703-3427-11) > 20 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0703-3427 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ifosfamide |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20070726 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc. |
| Substance Name | IFOSFAMIDE |
| Strength Number | 1 |
| Strength Unit | g/20mL |
| Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |